Laura A. Tan, Ph.D. - Publications

Affiliations: 
Salk Institute for Biological Studies, La Jolla, CA, United States 
Area:
corticotropin-releasing factor, Alzheimer's disease

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Hogg DW, Chen Y, D'Aquila AL, Xu M, Husic M, Tan LA, Bull C, Lovejoy DA. A novel role of the corticotropin-releasing hormone (CRH) regulating peptide, teneurin-1 C-terminal associated peptide (TCAP-1), on glucose uptake into the brain. Journal of Neuroendocrinology. PMID 29411913 DOI: 10.1111/Jne.12579  0.6
2017 Tan LA, Vaughan JM, Perrin MH, Rivier JE, Sawchenko PE. Distribution of Corticotropin-Releasing Factor (CRF) Receptor Binding in the Mouse Brain Using a New, High-Affinity Radioligand, [(125) I]-PD-Sauvagine. The Journal of Comparative Neurology. PMID 28842924 DOI: 10.1002/Cne.24307  0.44
2015 Perrin MH, Tan LA, Vaughan JM, Lewis KA, Donaldson CJ, Miller C, Erchegyi J, Rivier JE, Sawchenko PE. Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies. The Journal of Pharmacology and Experimental Therapeutics. 353: 307-17. PMID 25736419 DOI: 10.1124/Jpet.114.222307  0.44
2014 Grieder TE, Herman MA, Contet C, Tan LA, Vargas-Perez H, Cohen A, Chwalek M, Maal-Bared G, Freiling J, Schlosburg JE, Clarke L, Crawford E, Koebel P, Repunte-Canonigo V, Sanna PP, et al. VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation. Nature Neuroscience. 17: 1751-8. PMID 25402857 DOI: 10.1038/Nn.3872  0.6
2012 Tan LA, Chand D, De Almeida R, Xu M, De Lannoy L, Lovejoy DA. Modulation of neuroplastic changes and corticotropin-releasing factor-associated behavior by a phylogenetically ancient and conserved peptide family. General and Comparative Endocrinology. 176: 309-13. PMID 22138219 DOI: 10.1016/J.Ygcen.2011.11.011  0.6
2011 Tan LA, Al Chawaf A, Vaccarino FJ, Boutros PC, Lovejoy DA. Teneurin C-terminal associated peptide (TCAP)-1 modulates dendritic morphology in hippocampal neurons and decreases anxiety-like behaviors in rats. Physiology & Behavior. 104: 199-204. PMID 21411044 DOI: 10.1016/J.Physbeh.2011.03.015  0.6
2010 Rotzinger S, Lovejoy DA, Tan LA. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides. 31: 736-56. PMID 20026211 DOI: 10.1016/J.Peptides.2009.12.015  0.6
2009 Tan LA, Xu K, Vaccarino FJ, Lovejoy DA, Rotzinger S. Teneurin C-terminal associated peptide (TCAP)-1 attenuates corticotropin-releasing factor (CRF)-induced c-Fos expression in the limbic system and modulates anxiety behavior in male Wistar rats. Behavioural Brain Research. 201: 198-206. PMID 19428634 DOI: 10.1016/J.Bbr.2009.02.013  0.6
2008 Tan LA, Xu K, Vaccarino FJ, Lovejoy DA, Rotzinger S. Repeated intracerebral teneurin C-terminal associated peptide (TCAP)-1 injections produce enduring changes in behavioral responses to corticotropin-releasing factor (CRF) in rat models of anxiety. Behavioural Brain Research. 188: 195-200. PMID 18082275 DOI: 10.1016/J.Bbr.2007.10.032  0.6
2007 Al Chawaf A, Xu K, Tan L, Vaccarino FJ, Lovejoy DA, Rotzinger S. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1). Peptides. 28: 1406-15. PMID 17644218 DOI: 10.1016/J.Peptides.2007.05.014  0.6
Show low-probability matches.